tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Inspire Medical Systems CFO to Step Down

Story Highlights
Inspire Medical Systems CFO to Step Down

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Inspire Medical Systems ( (INSP) ) has provided an update.

Inspire Medical Systems announced that its Chief Financial Officer, Richard J. Buchholz, will step down from his position effective December 31, 2025, to pursue other professional opportunities. Buchholz will remain in a financial advisory role until February 28, 2026, to ensure a smooth transition. The company has initiated a search for a new CFO and reaffirmed its 2025 financial guidance with expected revenues between $900 to $910 million. Buchholz has been instrumental in the company’s growth, contributing to its revenue increase from $4 million to over $800 million in 2024 and guiding it through its IPO and the challenges of the COVID-19 pandemic.

The most recent analyst rating on (INSP) stock is a Hold with a $97.00 price target. To see the full list of analyst forecasts on Inspire Medical Systems stock, see the INSP Stock Forecast page.

Spark’s Take on INSP Stock

According to Spark, TipRanks’ AI Analyst, INSP is a Neutral.

The overall stock score is primarily influenced by strong financial performance and positive corporate events. However, technical analysis indicates bearish trends, and valuation concerns due to a high P/E ratio weigh down the score. Mixed earnings call sentiment also impacts the overall assessment.

To see Spark’s full report on INSP stock, click here.

More about Inspire Medical Systems

Inspire Medical Systems is a medical technology company that focuses on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea. Their proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Average Trading Volume: 932,305

Technical Sentiment Signal: Sell

Current Market Cap: $2.75B

For an in-depth examination of INSP stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1